Back to Results
First PageMeta Content
Organochlorides / Fenofibrate / Ketones / Prodrugs / Merck / Statin / Simvastatin / Low-density lipoprotein / Niacin / Chemistry / Organic chemistry / Fibrates


1) Please comment on the findings of glucose intolerance and development of diabetes associated with Egrifta (tesamorelin) therapy and its impact on long-term cardiovascular risk
Add to Reading List

Open Document

File Size: 17,97 KB

Share Result on Facebook
UPDATE